Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of BioClinica, Inc. Shareholders

  Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of
  BioClinica, Inc. Shareholders

Business Wire

NEW YORK -- January 30, 2013

Kirby McInerney LLP is investigating potential claims against the Board of
Directors of BioClinica, Inc. (“BioClinica” or the “Company”) (NASDAQ: BIOC)
related to the proposed acquisition of the Company by JLL Partners, Inc., a
private equity firm. Under the terms of the agreement, JLL Partners will
commence a cash tender offer to purchase all of BioClinica’s common stock for
$7.25 per share, valuing the Company at approximately $123 million.

The investigation concerns whether the BioClinica Board of Directors violated
its fiduciary duties by agreeing to this transaction and whether the proposed
$7.25 per share consideration adequately values BioClinica shares. The offer
price represents a 19% premium to the closing price of BioClinica shares the
day prior to the announcement. At least one analyst has a price target for the
Company’s stock of $9.00 per share, 24% above the offer price.

If you are a BioClinica shareholder and wish to obtain additional information,
please contact J.Brandon Walker, Esq. by email at bwalker@kmllp.com, or by
telephone at (212) 699-1145 or (888) 529-4787, or by filling out this contact
form.

Kirby McInerney LLP is a New York-based law firm concentrating in securities,
shareholder, whistleblower, antitrust and consumer litigation. For additional
information, please go to www.kmllp.com.

Contact:

Kirby McInerney LLP
J.Brandon Walker, Esq.
212-699-1145
888-529-4787
bwalker@kmllp.com
 
Press spacebar to pause and continue. Press esc to stop.